# A Study of AS-101 in Patients With AIDS or AIDS Related Complex (ARC)

> **NCT00001006** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 30 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** AS-101

## Key facts

- **NCT ID:** NCT00001006
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 1993-03
- **Target enrollment:** 30 (—)
- **Last updated:** 2021-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001006, "A Study of AS-101 in Patients With AIDS or AIDS Related Complex (ARC)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00001006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*